Michael Scolaro

Michael Scolaro

Sep 20, 2017

Group 6 Copy 142
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can a Meal Replacement Help Solve Hunger in America?

In the United States, hunger is commonplace. 42 million Americans struggle to get the healthy foods they need...

Exploring an age-old question: Can we demystify skin color?

In 2005, our lab uncovered one of the most pervasive genetic mutations on SLC24A5, the contributor to the light...

Are current antibacterial treatments resulting in the evolution of more virulent multidrug resistant bacteria?

Each year in the U.S. 23,000 people die as a direct result of antibiotic resistant infections. I hypothesize...

Backer Badge Funded